Letter: More Time Communicating

John Wilkes' article, "Scientists Should Spend More Time Communicating With The Public," is touching but naive. He may have made it from the role of closet scientist to that of teaching scientist literacy, and I agree that there must be at least a smattering of researchers out there with both talent and interest enough to make their work attractive to the poor old layman, but is this really the point? A substantial part of my income is generated from science writing and freelance writing for a

Written byMarc Nicholls
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

John Wilkes' article, "Scientists Should Spend More Time Communicating With The Public," is touching but naive. He may have made it from the role of closet scientist to that of teaching scientist literacy, and I agree that there must be at least a smattering of researchers out there with both talent and interest enough to make their work attractive to the poor old layman, but is this really the point?

A substantial part of my income is generated from science writing and freelance writing for a variety of general newspapers and magazines. I doubt whether the reintegration of science into American (or any other) life at this point is much more than wishful thinking. The popular press is generally loath to carry science features, save for those with some medical repercussions ("Okay," editors will say when you submit your proposal, "but can you come up with an angle that'll actually ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies